Maculopapular-type drug eruption caused by entecavir

被引:6
作者
Yamada, Shigenori [1 ]
Sawada, Yu [1 ]
Nakamura, Motonobu [1 ]
机构
[1] Univ Occupat & Environm Hlth, Dept Dermatol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan
关键词
CHRONIC HEPATITIS-B;
D O I
10.1684/ejd.2011.1411
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:635 / 636
页数:2
相关论文
共 5 条
[1]   Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection [J].
de Man, RA ;
Wolters, LMM ;
Nevens, F ;
Chua, D ;
Sherman, M ;
Lai, CL ;
Gadano, A ;
Lee, Y ;
Mazzotta, F ;
Thomas, N ;
DeHertogh, D .
HEPATOLOGY, 2001, 34 (03) :578-582
[2]   Drug-induced exanthemata: a source of clinical and intellectual confusion [J].
Friedmann, Peter Simon ;
Pickard, Christopher ;
Ardern-Jones, Michael ;
Bircher, Andreas J. .
EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (03) :255-259
[3]   Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with Entecavir in Patients with Impaired Liver Function [J].
Lange, Christian M. ;
Bojunga, Joerg ;
Hofmann, Wolf Peter ;
Wunder, Katrin ;
Mihm, Ulrike ;
Zeuzem, Stefan ;
Sarrazin, Christoph .
HEPATOLOGY, 2009, 50 (06) :2001-2006
[4]   Immediate allergy, drug-induced eruption, by entecavir [J].
Sugiura, K. ;
Sugiura, M. ;
Takashi, T. ;
Naoki, H. ;
Itoh, A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (04) :487-489
[5]  
Zhang J., 2010, PLOS ONE, V5, P1